Weiss Multi-Strategy Advisers’s Edwards Lifesciences EW Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-5,000	Closed	-$373K	–	661
2022 Q4	$373K	Buy	5,000 +2,500	+100%	+$193K	0.01%	529
2022 Q3	$207K	Buy	+2,500	New	+$241K	0.01%	606
2019 Q2	–	Sell	-15,000	Closed	-$957K	–	552
2019 Q1	$957K	Buy	+15,000	New	+$856K	0.02%	397
2016 Q2	–	Sell	-15,000	Closed	-$441K	–	438
2016 Q1	$441K	Buy	+15,000	New	+$414K	0.02%	397
2014 Q2	–	Sell	-30,000	Closed	-$371K	–	777
2014 Q1	$371K	Buy	+30,000	New	+$346K	0.01%	776

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Weiss Multi-Strategy Advisers's EW Position: Q4 2023 in Review

Weiss Multi-Strategy Advisers sold out of Edwards Lifesciences (EW) in Q4 2023, closing a stake of 41,345 shares — an estimated $2.86M sold.

Weiss Multi-Strategy Advisers first reported a position in EW in Q2 2013 and held it in 42 quarters. The position peaked at $14.5M in Q1 2023. 1,244 funds tracked by Wall St. Rank hold EW as of Q4 2023.

Weiss Multi-Strategy Advisers reported no remaining Edwards Lifesciences position as of Q4 2023 after selling out during the quarter.
Weiss Multi-Strategy Advisers sold 41,345 Edwards Lifesciences shares in Q4 2023, an estimated $2.86M.
Weiss Multi-Strategy Advisers first reported a position in Edwards Lifesciences in Q2 2013 and held it in 42 quarters.
Weiss Multi-Strategy Advisers's Edwards Lifesciences position peaked at $14.5M in Q1 2023.
1,244 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2023.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q4 2023, filed 14 Feb 2024.